Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Dincer, C. Hasbal, B. Yavas, S. Himmetoglu, S. Hatipoglu, E. Koc, T. Akcay (Istanbul, Turkey). DNA damage and glutathione level in children with asthma bronchiale: effect of antiasthmatic therapy. Eur Respir J 2009; 34: Suppl. 53, 1207

Member's Comments

No comment yet.

Related content which might interest you: COPD and asthma: the effect of glucocorticosteroid therapy on tolerance to physical activity Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Effectiveness of N-acetylcysteine in correction of oxidative stress in combined therapy in patients with severe bronchial asthma Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 Efficacy of antiepileptic drugs diphenine and carbamazepine in pharmacotherapy of children with bronchial asthma: is asthma a neurogenic inflammatory disease? Source: Eur Respir J 2006; 28: Suppl. 50, 204s Year: 2006 S-Nitrosothiols formation/consumption is not related to lipid peroxidation activity and level of reduced glutathione in severe atopic asthma in children Source: Eur Respir J 2003; 22: Suppl. 45, 401s Year: 2003 Children with mild asthma: do they benefit from inhaled corticosteroids? Source: Eur Respir J 2002; 20: 1470-1475 Year: 2002 Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Immunological effectiveness of N-acetylcystein in complex therapy in severe persistent bronchial asthma patients Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Inhaled corticosteroids and β2-agonists reduces imbalance in the cellular redox status in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004 Prevention of exercise-induced bronchospasm in children with asthma: a comparison of different anti-inflammatory combination therapy Source: Eur Respir J 2002; 20: Suppl. 38, 387s Year: 2002 The activity of anti-oxidative enzymes in subjects with asthma and bronchial hyperreactivity Source: Annual Congress 2005 - Novelties in asthma progression and risks Year: 2005 Simultaneous assessment of DNA damage and antioxidant enzyme activity in COPD exacerbations Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Anti-IgE treatment in children with severe intrinsic asthma Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Effect of montelukast on excessive airway narrowing in adult asthmatics not on controller therapy Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006 Efficacy of low dose theophylline in patient with bronchial asthma - anti-inflammatory effect Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003 Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006 Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Pharmacogenetics of anti-inflammatory treatment in children with asthma Source: Annual Congress 2013 –Towards personalised medicine in respiratory diseases in children Year: 2013